- Home
- DTIL vs ELVA Comparison
DTIL vs ELVA Comparison
Compare DTIL & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTIL | ELVA |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.5M | 125.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | DTIL | ELVA |
|---|---|---|
| Price | $4.05 | $7.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $47.00 | $8.38 |
| AVG Volume (30 Days) | 235.6K | ★ 675.9K |
| Earning Date | 11-03-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $698,000.00 | ★ $63,826,000.00 |
| Revenue This Year | N/A | $40.20 |
| Revenue Next Year | $34.30 | $49.84 |
| P/E Ratio | ★ N/A | $98.75 |
| Revenue Growth | N/A | ★ 43.06 |
| 52 Week Low | $3.61 | $1.80 |
| 52 Week High | $8.82 | $7.99 |
Technical Indicators
Market Signals| Indicator | DTIL | ELVA |
|---|---|---|
| Relative Strength Index (RSI) | 30.63 | 72.31 |
| Support Level | $4.14 | $7.55 |
| Resistance Level | $4.43 | $7.97 |
| Average True Range (ATR) | 0.26 | 0.47 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 8.30 | 75.91 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.